News & Updates

Use of topical netarsudil 0.02% for the treatment of glaucoma results in the development of reversible punctal stenosis, a recent study has found. This inflammation-mediated stenosis can cause tearing and related symptoms and may lead to treatment discontinuation with sufficient severity.

COVID-19 patients remain on the recovery phase 6 months after hospital admission, with persistent fatigue but improving lung function and quality of life, according to a study.

In the week-96 analysis of the phase III ASCEMBL trial, the first BCR::ABL1 STAMP* inhibitor asciminib sustained superiority over bosutinib for individuals with CML-CP** who have failed ≥2 lines of prior tyrosine kinase inhibitors (TKIs).

Insomnia may play a role in manifestation of attention deficit hyperactivity disorder (ADHD) symptoms and has a negative effect on cognitive abilities of children with ADHD, according to a cross-sectional study by the University of Hong Kong (HKU), the Chinese University of Hong Kong (CUHK) and Alice Ho Miu Ling Nethersole Hospital. 

Adolescents and adults with severe uncontrolled asthma while on inhaled corticosteroids (ICS) had greater responses to the human monoclonal antibody tezepelumab than placebo, according to prespecified exploratory results of the phase III NAVIGATOR trial.